In preclinical studies, a team of researchers report new findings on a therapeutic combination that regenerated human insulin-producing beta cells, providing a possible new treatment for diabetes.

Itakura, K. et al. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198, 1056–1063 (1977). Crea, R. et al. Chemical synthesis of genes for ...

Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers to genetically engineer bacteria to produce human insulin. This “recombinant insulin” first came on ...

Beta islets, by contrast, produce the glucose-lowering hormone insulin. When beta cells are missing or irreparably impaired, glucose control goes awry, and type 1 diabetes can result.

These patent applications are filed through the Icahn School of Medicine at Mount Sinai and are currently unlicensed. # # # About City of Hope ...

Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity ...

Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers to genetically engineer bacteria to produce human insulin. This “recombinant insulin” first came on ...

Next Tuesday, October 29 th, marks the 42nd anniversary of one of biotechnology's most significant milestones — the approval by the FDA of human insulin synthesized in genetically engineered bacteria ...

In 2023, the U.S. Food and Drug Administration approved a therapy using pancreatic cells from deceased donors intended to replace insulin-producing cells lost in people with type 1 diabetes.

July 2 (Reuters) - Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress, opens new tab underway in London ...